Dr. Lal PathLabs surges 16% on strong Q4 results

The stock surged 16% to Rs 931, also its 52-week high on the BSE in intra-day trade after the company reported a better than expected 27% YoY growth in net profit at Rs 402 million in Q4FY18.

Shares of Dr. Lal PathLabs have surged by 16% to Rs 931 per share, also their 52-week high on the BSE in intra-day trade after the company reported a better than expected 27% year on year (YoY) growth in net profit at Rs 402 million in March quarter (Q4FY18). The company had profit of Rs 316 million in year ago quarter.

Total revenue during the quarter under review grew 21.4% at Rs 2,668 million against Rs 2,199 million in the corresponding quarter of previous fiscal. EBITDA (earnings before interest, tax, depreciation and amortization) margins improved 100bps to 25.8% from